目次

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 KEY STAKEHOLDERS

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
2.2.1 SECONDARY DATA
2.2.1.1 Key secondary sources
2.2.1.2 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Primary sources
2.2.2.2 Key data from primary sources
2.2.2.3 Key industry insights
2.2.2.4 Breakdown of primary interviews
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation approach
2.3.1.2 Approach 2: Presentations of companies and primary interviews
2.3.1.3 Growth forecast
2.3.1.4 CAGR projections
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 MARKET SHARE ASSESSMENT
2.6 RESEARCH ASSUMPTIONS
2.6.1 PARAMETRIC ASSUMPTIONS
2.7 RESEARCH LIMITATIONS
2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY
3.1 KEY INSIGHTS & MARKET HIGHLIGHTS
3.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS & STRATEGIC DEVELOPMENTS
3.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
3.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
3.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

4 PREMIUM INSIGHTS
4.1 IVD LABWARE MARKET OVERVIEW
4.2 IVD LABWARE MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
4.3 IVD LABWARE MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
4.4 IVD LABWARE MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
4.5 IVD LABWARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
4.6 IVD LABWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising volume of diagnostic testing for chronic & infectious diseases
5.2.1.2 Technological advancements in laboratories
5.2.1.3 Expansion of diagnostic laboratories and healthcare infrastructure
5.2.1.4 Growing demand for advanced labware materials
5.2.2 RESTRAINTS
5.2.2.1 High cost of advanced labware
5.2.2.2 Environmental sustainability concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Growing demand for sustainable and eco-friendly consumables
5.2.3.2 Growth potential of emerging markets
5.2.4 CHALLENGES
5.2.4.1 Need for regulatory compliance
5.2.4.2 Lack of awareness and skills for advanced consumables
5.3 UNMET NEEDS & WHITE SPACES
5.3.1 UNMET NEEDS IN IVD LABWARE MARKET
5.3.2 WHITE SPACE OPPORTUNITIES
5.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
5.4.1 INTERCONNECTED MARKETS
5.4.2 CROSS-SECTOR OPPORTUNITIES
5.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
5.5.1 KEY MOVES AND STRATEGIC FOCUS

6 INDUSTRY TRENDS
6.1 PORTER’S FIVE FORCES ANALYSIS
6.1.1 THREAT OF NEW ENTRANTS
6.1.2 THREAT OF SUBSTITUTES
6.1.3 BARGAINING POWER OF BUYERS
6.1.4 BARGAINING POWER OF SUPPLIERS
6.1.5 INTENSITY OF COMPETITIVE RIVALRY
6.2 MACROECONOMIC INDICATORS
6.2.1 INTRODUCTION
6.2.2 GDP TRENDS AND FORECAST
6.3 SUPPLY CHAIN ANALYSIS
6.4 VALUE CHAIN ANALYSIS
6.5 ECOSYSTEM ANALYSIS
6.5.1 IVD LABWARE MARKET: ROLE OF COMPANIES IN ECOSYSTEM
6.6 PRICING ANALYSIS
6.6.1 AVERAGE SELLING PRICE TREND OF IVD LABWARE, BY PRODUCT,
2023-2025
6.6.2 AVERAGE SELLING PRICE TREND OF PLASTIC LABWARE,
BY KEY PLAYER, 2023-2025
6.6.3 AVERAGE SELLING PRICE TREND OF IVD LABWARE PRODUCTS,
BY REGION, 2023-2025
6.7 TRADE ANALYSIS
6.7.1 IMPORT SCENARIO (HS CODE 7017)
6.7.2 EXPORT SCENARIO (HS CODE 7017)
6.8 KEY CONFERENCES & EVENTS, 2025-2026
6.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
6.10 INVESTMENT & FUNDING SCENARIO
6.11 CASE STUDY ANALYSIS
6.11.1 CASE STUDY 1: IMPLEMENTATION OF CUSTOMIZED PIPETTING SYSTEM IN A MOLECULAR DIAGNOSTIC WORKFLOW
6.11.2 CASE STUDY 2: QUANTITATIVE COMPETITIVE PCR ASSAY FOR HIV-1 USING A MICROPLATE-BASED DETECTION APPROACH
6.11.3 CASE STUDY 3: MICROFLUIDIC PCR TUBE INTEGRATION FOR ON-TUBE PURIFICATION AND AMPLIFICATION
6.12 IMPACT OF 2025 US TARIFFS ON IVD LABWARE MARKET
6.12.1 INTRODUCTION
6.12.2 KEY TARIFF RATES
6.12.3 PRICE IMPACT ANALYSIS
6.12.4 KEY IMPACT ON COUNTRY/REGION
6.12.4.1 North America
6.12.4.2 Europe
6.12.4.3 Asia Pacific
6.12.5 IMPACT ON END-USE INDUSTRIES
6.12.5.1 Hospitals
6.12.5.2 Clinical laboratories
?

7 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
7.1 KEY EMERGING TECHNOLOGIES
7.1.1 IMMUNOASSAYS
7.1.2 MOLECULAR DIAGNOSTICS
7.1.3 CLINICAL CHEMISTRY
7.1.4 MICROBIOLOGY
7.2 COMPLEMENTARY TECHNOLOGIES
7.2.1 MICROFLUIDICS AND LAB-ON-A-CHIP PLATFORMS
7.3 TECHNOLOGY/PRODUCT ROADMAP
7.3.1 SHORT TERM (2025-2027) | PROCESS IMPROVEMENT & STANDARDIZATION
7.3.1.1 Focus areas:
7.3.1.1.1 Material development
7.3.1.1.2 Product innovations
7.3.1.1.3 Market adoption
7.3.2 MID TERM (2027-2030) | MATERIAL DIVERSIFICATION & SUSTAINABILITY
7.3.2.1 Focus areas:
7.3.2.1.1 Material development
7.3.2.1.2 Product innovations
7.3.2.1.3 Market adoption
7.3.3 LONG TERM (2030-2035+) | HIGH-PERFORMANCE & ECO-EFFICIENT LABWARE
7.3.3.1 Focus areas:
7.3.3.1.1 Material development
7.3.3.1.2 Product innovations
7.3.3.1.3 Market adoption
7.4 PATENT ANALYSIS
7.4.1 LIST OF MAJOR PATENTS
7.5 FUTURE APPLICATIONS
7.6 IMPACT OF AI/GENERATIVE AI ON IVD LABWARE MARKET
7.6.1 INTRODUCTION
7.6.2 TOP USE CASES & MARKET POTENTIAL
7.6.3 AI USE CASES
7.6.4 IMPLEMENTATION OF AI, BY KEY COMPANY AND USE CASE
7.6.5 FUTURE OF AI IN IVD LABWARE MARKET

8 SUSTAINABILITY AND REGULATORY LANDSCAPE
8.1 REGIONAL REGULATIONS AND COMPLIANCE
8.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8.1.2 INDUSTRY STANDARDS
8.2 SUSTAINABILITY INITIATIVES
8.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN IVD LABWARE
8.2.1.1 Eco-friendly Initiatives
8.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
8.4 CERTIFICATIONS, LABELING, ECO-STANDARDS

9 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
9.1 DECISION-MAKING PROCESS
9.2 KEY STAKEHOLDERS & BUYING EVALUATION CRITERIA
9.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
9.2.2 BUYING CRITERIA
9.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
9.4 UNMET NEEDS IN VARIOUS END-USER INDUSTRIES
9.5 MARKET PROFITABILITY
9.5.1 REVENUE POTENTIAL
9.5.2 COST DYNAMICS
9.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

10 IVD LABWARE MARKET, BY PRODUCT
10.1 INTRODUCTION
10.2 PLASTIC LABWARE
10.2.1 TUBES
10.2.1.1 Centrifuge/Microcentrifuge tubes
10.2.1.1.1 Growing demand for molecular and biochemical testing to drive adoption
10.2.1.2 PCR tubes
10.2.1.2.1 Growing adoption of molecular diagnostics to boost demand for PCR tubes
10.2.1.3 Cryovials/Storage vials
10.2.1.3.1 Rising need for secure sample preservation to support demand
10.2.1.4 Culture tubes
10.2.1.4.1 Rising focus on efficient sample cultivation to fuel demand
10.2.1.5 Other tubes
10.2.2 PLATES
10.2.2.1 Microplates
10.2.2.1.1 Automation and standardization to support use of microplates
10.2.2.2 PCR plates
10.2.2.2.1 Rising incidence of infectious diseases to drive demand for PCR plates
10.2.2.3 Deep-well plates for sample preparation/extraction
10.2.2.3.1 Growing demand for high-throughput and automated sample handling to support growth
10.2.2.4 Cell culture plates
10.2.2.4.1 Increasing adoption of cell-based diagnostic methods to drive demand
10.2.2.5 Other plates
10.2.2.5.1 Increasing adoption of cell-based diagnostic methods to drive demand
10.2.3 PIPETTES
10.2.3.1 Rising emphasis on accuracy in liquid handling to boost market demand
10.2.4 PETRI DISHES & CUVETTES
10.2.4.1 Growing incidence of infectious diseases and metabolic disorders to fuel adoption
10.2.5 OTHER PLASTIC LABWARE PRODUCTS
10.3 GLASS LABWARE
10.3.1 TEST TUBES
10.3.1.1 Rising need for contamination-free sample handling to boost market growth
10.3.2 BEAKERS & FLASKS
10.3.2.1 Increased need for precise reagent preparation in diagnostics to drive adoption
10.3.3 VIALS
10.3.3.1 Rising focus on maintaining sample purity to boost demand
10.3.4 PETRI DISHES & CUVETTES
10.3.4.1 Increasing demand for precision and contamination control to support market growth
10.3.5 SLIDES & COVERSLIPS
10.3.5.1 Expanding use of microscopy in diagnostics to fuel adoption
10.3.6 OTHER GLASS LABWARE PRODUCTS
10.4 OTHER IVD LABWARE PRODUCTS

11 IVD LABWARE MARKET, BY TYPE
11.1 INTRODUCTION
11.2 SINGLE-USE LABWARE
11.2.1 NEED FOR EFFECTIVE INFECTION CONTROL AND PREVENTION OF CROSS-CONTAMINATION TO SUPPORT DEMAND
11.3 REUSABLE LABWARE
11.3.1 RISING INCIDENCE OF CHRONIC DISEASES TO PROVIDE OPPORTUNITIES FOR MARKET GROWTH

12 IVD LABWARE MARKET, BY APPLICATION
12.1 INTRODUCTION
12.2 IMMUNOASSAYS
12.2.1 EXPANDING USE OF IVD LABWARE IN IMMUNOASSAY TESTING TO SUPPORT MARKET GROWTH
12.3 CLINICAL CHEMISTRY
12.3.1 RISING INCIDENCE OF CHRONIC DISEASES TO PROVIDE OPPORTUNITIES FOR MARKET GROWTH
12.4 MOLECULAR DIAGNOSTICS
12.4.1 GROWING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE DEMAND
12.5 HEMATOLOGY
12.5.1 INCREASING INCIDENCE OF BLOOD DISORDERS TO DRIVE ADOPTION OF IVD LABWARE
12.6 MICROBIOLOGY
12.6.1 INCREASING ADOPTION OF AUTOMATED CLINICAL MICROBIOLOGY TESTING INSTRUMENTS TO SUPPORT MARKET GROWTH
12.7 OTHER APPLICATIONS

13 IVD LABWARE MARKET, BY END USER
13.1 INTRODUCTION
13.2 HOSPITALS
13.2.1 LARGE VOLUME OF IVD TESTS PERFORMED TO SUPPORT MARKET GROWTH
13.3 CLINICAL LABORATORIES
13.3.1 EXPANDING DIAGNOSTIC WORKLOAD TO DRIVE LABWARE DEMAND
13.4 ACADEMIC INSTITUTES
13.4.1 EMPHASIS ON DIAGNOSTIC TRAINING IN ACADEMIC INSTITUTES TO BOOST MARKET GROWTH
13.5 OTHER END USERS

14 IVD LABWARE MARKET, BY REGION
14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 US
14.2.1.1 Presence of advanced healthcare infrastructure and high healthcare expenditures to drive the market
14.2.2 CANADA
14.2.2.1 Rising government initiatives to propel market growth
14.3 EUROPE
14.3.1 GERMANY
14.3.1.1 Increasing healthcare expenditure to drive market growth in Germany
14.3.2 UK
14.3.2.1 Growing number of accredited diagnostic & hospital laboratories to propel market
14.3.3 FRANCE
14.3.3.1 Increasing demand for early diagnosis to augment market growth
14.3.4 ITALY
14.3.4.1 Increased adoption of advanced diagnostic technologies and growing government healthcare investment to drive market
14.3.5 SPAIN
14.3.5.1 Growing disease burden and national initiatives to drive expansion of market
14.3.6 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 CHINA
14.4.1.1 Growing access to modern healthcare to boost market growth
14.4.2 JAPAN
14.4.2.1 Well-developed healthcare system to drive market
14.4.3 INDIA
14.4.3.1 Expanding healthcare access and rising disease prevalence to drive market growth
14.4.4 REST OF ASIA PACIFIC
14.5 LATIN AMERICA
14.5.1 BRAZIL
14.5.1.1 Universal healthcare access to drive adoption in Brazil
14.5.2 MEXICO
14.5.2.1 Improved access to healthcare to drive uptake of advanced diagnostic products
14.5.3 REST OF LATIN AMERICA
14.6 MIDDLE EAST & AFRICA
14.6.1 SAUDI ARABIA
14.6.1.1 Rising government healthcare expenditure to boost market
14.6.2 UAE
14.6.2.1 Improvements in healthcare infrastructure to support growth
14.6.3 REST OF MIDDLE EAST & AFRICA

15 IVD LABWARE MARKET: VOLUME ANALYSIS
15.1 INTRODUCTION
15.1.1 US: TOTAL NUMBER OF IVD TESTS CONDUCTED, 2023-2030 (MILLION)

16 COMPETITIVE LANDSCAPE
16.1 INTRODUCTION
16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
16.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN IVD LABWARE MARKET
16.3 REVENUE ANALYSIS, 2020-2024
16.4 MARKET SHARE ANALYSIS, 2024
16.4.1 GLOBAL MARKET SHARE ANALYSIS, 2024
16.4.2 US MARKET SHARE ANALYSIS, 2024
16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
16.5.1 STARS
16.5.2 EMERGING LEADERS
16.5.3 PERVASIVE PLAYERS
16.5.4 PARTICIPANTS
16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
16.5.5.1 Company footprint
16.5.5.2 Region footprint
16.5.5.3 Product footprint
16.5.5.4 Type footprint
16.5.5.5 Application footprint
16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
16.6.1 PROGRESSIVE COMPANIES
16.6.2 RESPONSIVE COMPANIES
16.6.3 DYNAMIC COMPANIES
16.6.4 STARTING BLOCKS
16.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
16.6.5.1 Detailed list of key startups/SMEs
16.6.5.2 Competitive benchmarking of startups/SMEs (1/2)
16.6.5.3 Competitive benchmarking of startups/SMEs (2/2)
16.7 COMPANY VALUATION & FINANCIAL METRICS
16.7.1 FINANCIAL METRICS
16.7.2 COMPANY VALUATION
16.8 BRAND/PRODUCT COMPARISON
16.9 COMPETITIVE SCENARIO
16.9.1 PRODUCT LAUNCHES & APPROVALS
16.9.2 DEALS
16.9.3 EXPANSIONS

17 COMPANY PROFILES
17.1 KEY PLAYERS
17.1.1 THERMO FISHER SCIENTIFIC INC.
17.1.1.1 Business overview
17.1.1.2 Products offered
17.1.1.3 Recent developments
17.1.1.3.1 Deals
17.1.1.3.2 Expansions
17.1.1.4 MnM view
17.1.1.4.1 Key strengths
17.1.1.4.2 Strategic choices
17.1.1.4.3 Weaknesses & competitive threats
17.1.2 GREINER AG
17.1.2.1 Business overview
17.1.2.2 Products offered
17.1.2.3 Recent developments
17.1.2.3.1 Product approvals
17.1.2.4 MnM view
17.1.2.4.1 Key strengths
17.1.2.4.2 Strategic choices
17.1.2.4.3 Weaknesses & competitive threats
17.1.3 AVANTOR, INC.
17.1.3.1 Business overview
17.1.3.2 Products offered
17.1.3.3 Recent developments
17.1.3.3.1 Deals
17.1.3.3.2 Expansions
17.1.3.4 MnM view
17.1.3.4.1 Key strengths
17.1.3.4.2 Strategic choices
17.1.3.4.3 Weaknesses & competitive threats
17.1.4 CORNING INCORPORATED
17.1.4.1 Business overview
17.1.4.2 Products offered
17.1.4.3 Recent developments
17.1.4.3.1 Deals
17.1.4.4 MnM view
17.1.4.4.1 Key strengths
17.1.4.4.2 Strategic choices
17.1.4.4.3 Weaknesses & competitive threats
17.1.5 EPPENDORF SE
17.1.5.1 Business overview
17.1.5.2 Products offered
17.1.5.3 Recent developments
17.1.5.3.1 Product launches & approvals
17.1.5.3.2 Deals
17.1.5.3.3 Expansions
17.1.5.4 MnM view
17.1.5.4.1 Key strengths
17.1.5.4.2 Strategic choices
17.1.5.4.3 Weaknesses & competitive threats
17.1.6 TARSONS PRODUCTS LIMITED
17.1.6.1 Business overview
17.1.6.2 Products offered
17.1.7 SARTORIUS AG
17.1.7.1 Business overview
17.1.7.2 Products offered
17.1.7.3 Recent developments
17.1.7.3.1 Expansions
17.1.8 SARSTEDT AG & CO. KG
17.1.8.1 Business overview
17.1.8.2 Products offered
17.1.9 ABBOTT LABORATORIES
17.1.9.1 Business overview
17.1.9.2 Products offered
17.1.9.3 Recent developments
17.1.9.3.1 Deals
17.1.10 BIOMÉRIEUX
17.1.10.1 Business overview
17.1.10.2 Products offered
17.1.11 QIAGEN N.V.
17.1.11.1 Business overview
17.1.11.2 Products offered
17.1.11.3 Recent developments
17.1.11.3.1 Expansions
17.1.12 SYSMEX CORPORATION
17.1.12.1 Business overview
17.1.12.2 Products offered
17.1.12.3 Recent developments
17.1.12.3.1 Expansions
17.1.13 SCG PACKAGING PUBLIC COMPANY LIMITED
17.1.13.1 Business overview
17.1.13.2 Products offered
17.1.13.3 Recent developments
17.1.13.3.1 Deals
17.2 OTHER PLAYERS
17.2.1 AZENTA, INC.
17.2.2 BRAND GROUP
17.2.3 GENAXY SCIENTIFIC PVT. LTD.
17.2.4 LABCON NORTH AMERICA
17.2.5 ACCUMAX LAB DEVICES PVT. LTD.
17.2.6 ZHEJIANG BIOLAND BIOTECHNOLOGY CO., LTD.
17.2.7 ABDOS GROUP
17.2.8 BEINGBIO
17.2.9 WUXI NEST BIOTECHNOLOGY CO., LTD.
17.2.10 BIOLYST SCIENTIFIC
17.2.11 HEATHROW SCIENTIFIC
17.2.12 KANGJIAN MEDICAL APPARATUS CO.
?

18 APPENDIX
18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS